To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia

NCT04500132 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: EC-18
DRUG: Placebo EC-18

Sponsor

Enzychem Lifesciences Corporation